mlsanityData to 14 Oct 2026

MADDIE: Multi-Agent Drug Discovery Engine

arXiv 2610.16975 ↗First posted 12 Oct 2026cs.AIcited by 0

On the map: LLM agents and tool use → Medical and scientific domain agents

Abstract (arXiv)

Drug discovery remains a resource-intensive and time-consuming process, involving billions of dollars and a decade of development to advance a drug to market. While many in silico tools have accelerated this process, operating them still demands substantial time, effort, and expertise from medicinal chemists. Autonomous systems built on Large Language Models (LLMs) have emerged as a promising solution, yet current designs limit their performance. Existing single-agent systems scale poorly to long-horizon, multi-step, and realistic tasks, whereas multi-agent systems typically execute predefined workflows that cannot capture the iterative, non-linear nature of a real drug discovery campaign. Here, we present MADDIE, a multi-agent drug discovery engine. It comprises a central agent, Orchestrator, and four specialized worker agents: HitIdentifier, LeadOptimizer, Synthesizer, and Evaluator, each representing a critical step in a drug discovery campaign. Under Orchestrator's orchestration and coordination, these worker agents are composed into flexible workflows, enabling MADDIE to adapt its strategy and navigate the drug discovery pipeline end-to-end. Across 50 protein targets, MADDIE produces molecules satisfying key property requirements and their synthesis routes, outperforming existing agentic systems, generative models, and general-purpose LLMs by a wide margin. Our analysis reveals how these agents collaborate and that MADDIE can employ different strategies across targets to achieve the campaign's goal, while still being efficient in time and tokens. Together, they demonstrate MADDIE as a low-cost, effective, and efficient autonomous engine for accelerating drug discovery. Code and dataset is available via https://github.com/ninglab/MADDIE.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. First posted on arXiv 12 Oct 2026.

Builds on

0 of 0 references.

No references here yet.

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2025MADD: Multi-Agent Drug Discovery Orchestra
  2. 2024DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration
  3. 2025FROGENT: An End-to-End Full-process Drug Design Multi-Agent System
  4. 2025AI Agents in Drug Discovery
  5. 2025LIDDIA: Language-based Intelligent Drug Discovery Agent
  6. 2025Can AI Agents Design and Implement Drug Discovery Pipelines?
  7. 2025LLM Agent Swarm for Hypothesis-Driven Drug Discovery
  8. 2026From Benchmark to Bench: Can Agents Survive Real-World Drug Discovery?